Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obeticholic Acid in Pediatric Biliary Atresia Post-Hepatoportoenterostomy
2023-503926-37-00Phase 3Completed
- Sponsor
- Intercept Pharmaceuticals
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 19
01
Overview
Phase 3, randomised, double-blind trial in biliary atresia comparing Obeticholic acid with Placebo (2 arms). Primary endpoints: Time to first clinical event composite, Time to death and 4 more. Started Apr 2024; status: completed.
02
Drugs
obeticholic acid
03
Conditions
biliary atresia
Beyond the preview
Go deeper on 2023-503926-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503926-37-00.